NEW YORK – Twist Bioscience reported a 42 percent increase in second quarter revenues after the close of the market on Thursday.
For the quarter ended March 31, Twist reported total revenues of $19.3 million, up from $13.6 million during the prior-year period. It beat analysts' average revenue estimate of $18.3 million.